# Safety of ENC-201-CED ENCRT

> **NCT06408311** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Encellin** · enrollment: 10 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **COMBINATION_PRODUCT:** ENC-201-CED hPI

## Key facts

- **NCT ID:** NCT06408311
- **Lead sponsor:** Encellin
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-05-01
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-10-30
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-03-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06408311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06408311, "Safety of ENC-201-CED ENCRT". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06408311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*